Enovix Co. (NASDAQ:ENVX) Shares Bought by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. grew its holdings in shares of Enovix Co. (NASDAQ:ENVXGet Rating) by 12.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 32,926 shares of the company’s stock after purchasing an additional 3,700 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Enovix were worth $604,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. grew its holdings in shares of Enovix by 5.2% in the 1st quarter. JPMorgan Chase & Co. now owns 106,242 shares of the company’s stock worth $1,516,000 after acquiring an additional 5,258 shares during the period. HighTower Advisors LLC grew its holdings in shares of Enovix by 18.8% in the 1st quarter. HighTower Advisors LLC now owns 33,723 shares of the company’s stock worth $483,000 after acquiring an additional 5,335 shares during the period. Citigroup Inc. grew its holdings in shares of Enovix by 129.2% in the 1st quarter. Citigroup Inc. now owns 20,144 shares of the company’s stock worth $287,000 after acquiring an additional 11,355 shares during the period. BlackRock Inc. grew its holdings in shares of Enovix by 1.2% in the 1st quarter. BlackRock Inc. now owns 1,498,054 shares of the company’s stock worth $21,376,000 after acquiring an additional 18,009 shares during the period. Finally, Vanguard Group Inc. grew its holdings in shares of Enovix by 5.4% in the 1st quarter. Vanguard Group Inc. now owns 3,059,143 shares of the company’s stock worth $43,654,000 after acquiring an additional 157,167 shares during the period. Institutional investors and hedge funds own 55.62% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. EF Hutton Acquisition Co. I started coverage on Enovix in a report on Friday, October 28th. They issued a “buy” rating and a $25.00 price target on the stock. Cowen lowered their target price on Enovix from $36.00 to $25.00 in a report on Wednesday, November 2nd. Canaccord Genuity Group started coverage on Enovix in a report on Wednesday, January 11th. They set a “buy” rating and a $20.00 target price on the stock. Janney Montgomery Scott started coverage on Enovix in a report on Friday, November 4th. They set a “buy” rating and a $23.00 target price on the stock. Finally, Cowen lowered their target price on Enovix from $36.00 to $25.00 in a report on Wednesday, November 2nd. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Enovix has a consensus rating of “Buy” and an average price target of $29.46.

Insider Buying and Selling

In related news, CTO Ashok Lahiri sold 2,000 shares of the stock in a transaction on Tuesday, January 3rd. The stock was sold at an average price of $12.81, for a total value of $25,620.00. Following the transaction, the chief technology officer now directly owns 1,358,265 shares of the company’s stock, valued at approximately $17,399,374.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, insider Gardner Cameron Dales sold 30,000 shares of the stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $18.55, for a total value of $556,500.00. Following the completion of the sale, the insider now owns 899,565 shares in the company, valued at $16,686,930.75. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CTO Ashok Lahiri sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, January 3rd. The shares were sold at an average price of $12.81, for a total value of $25,620.00. Following the sale, the chief technology officer now owns 1,358,265 shares in the company, valued at $17,399,374.65. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 41,000 shares of company stock valued at $740,870. 20.60% of the stock is currently owned by company insiders.

Enovix Stock Down 2.8 %

Shares of Enovix stock opened at $7.99 on Wednesday. The firm has a market cap of $1.26 billion, a PE ratio of -5.44 and a beta of 1.45. The business’s fifty day moving average is $10.77 and its two-hundred day moving average is $14.86. Enovix Co. has a fifty-two week low of $6.50 and a fifty-two week high of $26.30.

Enovix (NASDAQ:ENVXGet Rating) last issued its earnings results on Tuesday, November 1st. The company reported ($0.20) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.01. The firm had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.55 million. Equities research analysts anticipate that Enovix Co. will post -0.77 EPS for the current year.

Enovix Profile

(Get Rating)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. The company was founded in 2007 and is headquartered in Fremont, California.

Further Reading

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVXGet Rating).

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.